On 6 May 2026 at 07:30 (CEST), we will announce our financial results for the first quarter of 2026.
On 5 August 2026 at 07:30 (CEST), we will announce our financial results for the first half of 2026.
We will announce our full-year 2026 results before the opening of the NASDAQ Copenhagen stock exchange.
Date TBC
Timing and registration details coming soon.
J.P. Morgan Healthcare Conference
13 January 2026 - 9:45 PST / 6:45 PM CET
President and Chief Executive Officer Mike Doustdar participated in a fireside chat at the J.P. Morgan Healthcare Conference in San Francisco.
Quarterly results
Q3
5 November 2025
- Company announcement
- Investor presentation (iPaper)
- Download financial workbook (xlsx)
- Watch the Q3 investor webcast
- Watch the London conference call
Q2
6 August 2025
- Company announcement
- Download financial workbook (xlsx)
- Investor presentation (ipaper)
- Watch the Q2 2025 investor webcast
- Watch London Q2 earnings presentation
Q1
7 May 2025
- Company announcement
- Download financial workbook (xlsx)
- Investor presentation (ipaper)
- Watch the Q1 2025 investor webcast
- London conference call webcast
Other events
EGM
14 November 2025
Novo Nordisk to hold Extraordinary General Meeting on 14 November 2025.
Link to registration and documents
Conference call
21 October 2025
Novo Nordisk to hold Extraordinary General Meeting on 14 November 2025.
Link to conference call details
Conference call
9 October 2025
Novo Nordisk to acquire Akero Therapeutics Inc.
Listen to the conference call webcast
Go to the company announcement
R&D Investor Event
17 September 2025
Go to the R&D Investor Event (webcast)
Conference call
29 July 2025
Changes to executive leadership and the financial outlook for 2025
Listen to the conference call webcast
Go to the company announcement
R&D Investor Event
22 June 2025
Go to the R&D Investor Event webcast
Open the R&D Investor Event presentation (PDF)
Conference call
16 May 2025
Changes to our executive leadership and Board of Directors
Listen to the conference call webcast
Go to the company announcement
Annual General Meeting
27 March 2025
We held our Annual General Meeting on 27 March 2025
Watch recordings and download documents from our latest Annual General Meeting 2025
Annual Report 2024
Download
Go to the Annual report 2024 | 2024 i tilbageblik (iPaper)
Quarterly results
Q4
05 February 2025
Download financial workbook (xlsx)
Investor presentation (ipaper)
Go to the conference call webcast
Q3
06 November 2024
Download financial workbook (xlsx)
Investor presentation (ipaper)
Go to the conference call webcast
Go to the London conference call webcast
Q2
07 August 2024
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q1
02 May 2024
We announced our financial results for the three first months of 2024.
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Other events
J.P. Morgan’s Healthcare Conference
09 January 2024
Our CEO, Lars Fruergaard Jørgensen, presented at the Annual J.P. Morgan Healthcare Conference in San Francisco, USA on 09 January.
Capital Markets Day
07 March 2024
Our Capital Markets Day took place on the 7th of March.
Novo Nordisk Executive Management and other members of senior management provided a full review of our strategy, operations and financial targets.
Download the presentations and watch the webcast
Annual General Meeting
21 March 2024
We held our Annual General Meeting on 21 March 2024 at 14:00 CET.
Watch recordings and download documents from our latest Annual General Meeting.
Annual Report
Download
Annual report 2023 (pdf) | 2023 i tilbageblik (iPaper)
Quarterly results
Q4
Novo Nordisk A/S announced financial results for the full year of 2023:
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q3
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q2
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Q1
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
London earnings conference call (webcast)
Other events
Annual General Meeting
23 March 2023
Annual General Meeting (webcast)
Generalforsamling (webcast)
See previous AGM documentation
R&D investor call in relation to ADA 2023
26 June 2023
Presentation (Webcast)
Download presentation (pdf)
American Heart Association (AHA) conference
11-12 November 2023
Annual Report
Download Annual Report 2022 (pdf) | 2022 i tilbageblik (iPaper)
Quarterly results
Q4
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q3
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q2
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q1
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Other Events
Capital Markets Day
03 March 2022
Watch the presentations and get the slides from the Novo Nordisk Capital Markets Day
Annual General Meeting
24 March 2022
Annual General Meeting (webcast)
See previous Annual General Meeting documentation
Investor event (ADA 82nd Scientific Sessions)
5 June 2022
Download the ADA investor presentation (pdf)
Annual Report
Download Annual Report 2021 (pdf) | 2021 i tilbageblik (iPaper)
Quarterly results
Q4
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q3
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q2
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q1
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Other events
Conference call on supply situation for Wegovy®
20 December 2021
R&D investor call
28 June 2021
Approval of Wegovy™ in the US
7 June 2021
International Operations call
21 May 2021
Annual General Meeting
25 March 2021
Annual Report
Download Annual Report 2020 (pdf)
Quarterly results
Q4
Download company announcement (pdf)
Download financial workbook (xlsx)
Watch Novo Nordisk CEO reflect on the full year results 2021 (video)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q3
Download company Announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q2
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Q1
Download company announcement (pdf)
Download financial workbook (xlsx)
Investor presentation (iPaper)
Earnings conference call (webcast)
Oher events
Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update
16 December 2020
ESG conference call
30 November 2020
Download the ESG presentation (pdf)
Novo Nordisk raises sales and operating profit outlook for 2020
9 October 2020
R&D investor presentation
19 June 2020
Annual General Meeting
26 March 2020
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Investors
Share price
{{priceData.date}} {{priceData.time}}